California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment

NEWS | PROTON THERAPY | APRIL 25, 2019

Patients invited to participate in Proton Collaborative Group (PCG) Registry and clinical trial of partial breast irradiation in early-stage breast cancer

April 25, 2019 — California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast cancer treatment research involving its noninvasive, targeted proton therapy. Current California Protons patients as of Feb. 4, 2019, are invited to enroll in the Proton Collaborative Group (PCG) Registry of more than 13,000 patients. Separately, the PCG BRE007-12 Partial Breast Irradiation in early-stage breast cancer clinical trial will enroll around five to eight females per year.

The PCG Registry has been in existence since 2010. It is a prospective tracking study that allows for the collection and analysis of patient information to evaluate the disease process and treatment-related outcomes, thus defining strengths and weaknesses of proton radiation therapy. Qualified patients are invited to enroll in person at their first physician visit during treatment.

proton therapy - the use of protons instead of X-rays - in radiation therapy - specifically target tumors as protons don’t travel beyond the target so there’s a lower risk to healthy tissue.

38 proton radiation therapy centers in the United States.

175,000 patients have been treated worldwide.

25+ types of cancers can be treated with Proton Therapy